ATE494374T1 - Ingap-protein und dessen beteiligung an der neogenese pankreatischer inselzellen - Google Patents
Ingap-protein und dessen beteiligung an der neogenese pankreatischer inselzellenInfo
- Publication number
- ATE494374T1 ATE494374T1 AT96905368T AT96905368T ATE494374T1 AT E494374 T1 ATE494374 T1 AT E494374T1 AT 96905368 T AT96905368 T AT 96905368T AT 96905368 T AT96905368 T AT 96905368T AT E494374 T1 ATE494374 T1 AT E494374T1
- Authority
- AT
- Austria
- Prior art keywords
- participation
- cdna
- cell neogenesis
- identified
- ingap
- Prior art date
Links
- 101100189458 Mesocricetus auratus INGAP gene Proteins 0.000 title abstract 2
- 230000009707 neogenesis Effects 0.000 title abstract 2
- 239000002299 complementary DNA Substances 0.000 abstract 3
- 229920000298 Cellophane Polymers 0.000 abstract 2
- 241000699800 Cricetinae Species 0.000 abstract 1
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 210000001755 duct epithelial cell Anatomy 0.000 abstract 1
- 210000003890 endocrine cell Anatomy 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 210000000496 pancreas Anatomy 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/474—Pancreatic thread protein; Reg protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4733—Acute pancreatitis-associated protein
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/401,530 US5834590A (en) | 1995-02-22 | 1995-02-22 | Ingap protein involved in pancreatic islet neogenesis |
| US627195P | 1995-11-07 | 1995-11-07 | |
| PCT/US1996/001528 WO1996026215A1 (en) | 1995-02-22 | 1996-02-12 | Ingap protein involved in pancreatic islet neogenesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE494374T1 true ATE494374T1 (de) | 2011-01-15 |
Family
ID=26675411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96905368T ATE494374T1 (de) | 1995-02-22 | 1996-02-12 | Ingap-protein und dessen beteiligung an der neogenese pankreatischer inselzellen |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US5840531A (de) |
| EP (1) | EP0815129B1 (de) |
| JP (2) | JP4111539B2 (de) |
| AT (1) | ATE494374T1 (de) |
| CA (1) | CA2213610C (de) |
| DE (1) | DE69638315D1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6265165B1 (en) * | 1998-11-12 | 2001-07-24 | The Regents Of The University Of California | Methods for EST-specific full length cDNA cloning |
| US6986994B2 (en) * | 2001-01-09 | 2006-01-17 | Gmp Endotherapeutics, Inc. | INGAP displacement assays |
| US20040158036A1 (en) * | 2001-03-01 | 2004-08-12 | Lawrence Rosenberg | Neuritogenic compound and uses thereof |
| US6642003B2 (en) | 2001-08-02 | 2003-11-04 | Cedars-Sinai Medical Center | Human glucose-dependent insulin-secreting cell line |
| US20040132644A1 (en) * | 2001-10-16 | 2004-07-08 | The Procter & Gamble Company | Composition and method for treating diabetes |
| US7662768B2 (en) * | 2002-01-11 | 2010-02-16 | Mcgill University | Transdifferentiation of pancreatic acinar cells |
| US7355024B2 (en) * | 2002-01-11 | 2008-04-08 | Gmp Endotherapeutics, Inc. | Regulatory sequences for modulation of INGAP expression and reporter constructs |
| US7166439B2 (en) * | 2002-03-01 | 2007-01-23 | Gmp Endotherapeutics, Inc. | Assay for anti-INGAP antibodies |
| US7141240B2 (en) * | 2002-03-12 | 2006-11-28 | Cedars-Sinai Medical Center | Glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding GLP-1 |
| US20090142338A1 (en) * | 2005-03-04 | 2009-06-04 | Curedm, Inc. | Methods and Compositions for Treating Type 1 and Type 2 Diabetes Mellitus and Related Conditions |
| US8211430B2 (en) * | 2005-03-04 | 2012-07-03 | Curedm Group Holdings, Llc | Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions |
| CA2609667C (en) * | 2005-05-25 | 2011-02-22 | Curedm, Inc. | Human proislet peptide, derivatives and analogs thereof, and methods of using same |
| WO2008064306A2 (en) * | 2006-11-22 | 2008-05-29 | Curedm, Inc. | Methods and compositions relating to islet cell neogenesis |
| DK2193142T3 (da) * | 2007-08-30 | 2015-04-20 | Curedm Group Holdings Llc | Præparater og fremgangsmåder til anvendelse af pro-øcellepeptider og analoger dertil |
| US8012928B2 (en) * | 2008-12-19 | 2011-09-06 | The Research Foundation Of State University Of New York | Truncated PAP2 and methods of making and using same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4965188A (en) * | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| FR2700011B1 (fr) * | 1992-12-24 | 1995-02-24 | Inst Nat Sante Rech Med | Détection de la mucoviscidose ou d'une mutation du gêne CFTR au moyen d'un dosage de la PAP. |
| US5834590A (en) * | 1995-02-22 | 1998-11-10 | Eastern Virginia Medical School Of The Medical College Of Hampton Roads | Ingap protein involved in pancreatic islet neogenesis |
-
1996
- 1996-02-12 AT AT96905368T patent/ATE494374T1/de not_active IP Right Cessation
- 1996-02-12 EP EP96905368A patent/EP0815129B1/de not_active Expired - Lifetime
- 1996-02-12 JP JP52570296A patent/JP4111539B2/ja not_active Expired - Fee Related
- 1996-02-12 CA CA2213610A patent/CA2213610C/en not_active Expired - Lifetime
- 1996-02-12 DE DE69638315T patent/DE69638315D1/de not_active Expired - Lifetime
- 1996-09-09 US US08/709,662 patent/US5840531A/en not_active Expired - Lifetime
-
2000
- 2000-11-22 US US09/717,095 patent/USRE39062E1/en not_active Expired - Lifetime
-
2007
- 2007-05-09 JP JP2007124746A patent/JP2007291114A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0815129B1 (de) | 2011-01-05 |
| US5840531A (en) | 1998-11-24 |
| USRE39062E1 (en) | 2006-04-11 |
| JP2007291114A (ja) | 2007-11-08 |
| CA2213610A1 (en) | 1996-08-29 |
| AU708499B2 (en) | 1999-08-05 |
| JPH11500907A (ja) | 1999-01-26 |
| EP0815129A4 (de) | 2000-08-16 |
| DE69638315D1 (de) | 2011-02-17 |
| MX9706418A (es) | 1998-07-31 |
| CA2213610C (en) | 2013-12-03 |
| EP0815129A1 (de) | 1998-01-07 |
| JP4111539B2 (ja) | 2008-07-02 |
| AU4914996A (en) | 1996-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE494374T1 (de) | Ingap-protein und dessen beteiligung an der neogenese pankreatischer inselzellen | |
| AU6824994A (en) | An intraluminal stent graft | |
| DE69426946D1 (de) | Brennstoffsteuerungssystem für stufenbrenner | |
| DK0868505T3 (da) | Chondrogen in vitro induktion af humane mesenchymstamceller | |
| AU6351694A (en) | Human liver epithelial cell lines | |
| EP0773006A3 (de) | Selbstexpandierbarer Stent | |
| DE69629518D1 (de) | Mobilendgerät und Kontrollsystem für bewegte Körper | |
| AU1052597A (en) | Ostial stent balloon | |
| MX9709716A (es) | Metodos para incorporar substancias estables dentro de matrices de vidrio celular secas y composiciones obtenidas mediante los mismos. | |
| DE69527899D1 (de) | Herstellungsmethode für einen intraluminalen Stent | |
| IL122202A0 (en) | Bifurcated endovascular stent | |
| MX9709442A (es) | Metodo y composiciones para la inhibicion de interacciones entre proteina adaptadora y tirosinquinasa. | |
| NO982052L (no) | Selvekspanderende endoluminalt stent-transplantat | |
| ATE133179T1 (de) | Steroid-sulfatase-inhibitoren | |
| AU3121797A (en) | Intraluminal stent | |
| NO975557L (no) | Immortalisering og dissimortalisering av celler | |
| UA81398C2 (en) | Keratinocytes which may be used as biologically active substances for the treatment of wounds | |
| ATE314477T1 (de) | An der streptogramin biosynthese beteiligte polypeptide, ihre kodierenden nukleotidsequenzen und ihre verwendung | |
| FI854910A0 (fi) | Anordning foer distortionsfri utstrykning av display under en enskild bild. | |
| AU4751797A (en) | Defined systems for epithelial cell culture and use thereof | |
| AU5696796A (en) | Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses | |
| AU7082694A (en) | Hematopoietic stem cell proliferation accelerator | |
| DE69412848D1 (de) | Arbeitskammer für toxische umweltbedingungen | |
| NO985079L (no) | Eksplosiv formulering | |
| AU1771799A (en) | Acetyl-coa-carboxylase from candida albicans |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |